I-Mab banner

I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 3.98 USD 0.51% Market Closed
Market Cap: $325m

Profitability Summary

I-Mab's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
I-Mab

Margins Comparison
I-Mab Competitors

Country Company Market Cap Operating
Margin
Net
Margin
CN
I-Mab
NASDAQ:IMAB
325m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
389.4B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
193.8B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.6B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.4B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
74.1B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43B EUR
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
I-Mab Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
I-Mab
NASDAQ:IMAB
325m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
389.4B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
193.8B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.6B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.4B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
74.1B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
I-Mab

Last Value
3-Years Average
FCF Margin
Conversion Rate